Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy
Despite significant advances in cystic fibrosis (CF) treatments, a one-time treatment for this life-shortening disease remains elusive. Stable complementation of the disease-causing mutation with a normal copy of the CF transmembrane conductance regulator (CFTR) gene fulfills that goal. Integrating...
Main Authors: | Laura I. Marquez Loza, Ashley L. Cooney, Qian Dong, Christoph O. Randak, Stefano Rivella, Patrick L. Sinn, Paul B. McCray, Jr. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050121000358 |
Similar Items
-
Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
by: Laura I. Marquez Loza, et al.
Published: (2019-03-01) -
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease
by: Matthew D. Strub, et al.
Published: (2020-05-01) -
Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01) -
Lentiviral vectors transduce lung stem cells without disrupting plasticity
by: Ashley L. Cooney, et al.
Published: (2021-09-01) -
Expression and functional significance of the cystic fibrosis transmembrane conductance regulator (CFTR) in human mast cells
by: Dry, Ren
Published: (2009)